Evidence map›Paper›PMID 36823694›Full record

ArticleThe Journal of infectious diseases2023

MUC5AC Genetic Variation Is Associated With Tuberculous Meningitis Cerebral Spinal Fluid Cytokine Responses and Mortality.

Michelle C Sabo, Nguyen T T Thuong, Xuling Chang, Edwin Ardiansyah, Trinh T B Tram, Hoang T Hai, Ho D T Nghia, Nguyen D Bang, Sofiati Dian, A Rizal Ganiem and 11 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Chronic meningitis: diagnostic and therapeutic challenges.Current opinion in infectious diseases · 2025
    Review
  2. Article
  3. Article
  4. Structural and genetic diversity in the secreted mucins,bioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 7 countries.

Michelle C SaboDepartment of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-5058-3166
Nguyen T T ThuongOxford University Clinical Research Unit, Ho Chi Minh, Vietnam.
Xuling ChangDepartment of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia.
Edwin ArdiansyahRadboud University Medical Center, Nijmegen, The Netherlands.
Trinh T B TramOxford University Clinical Research Unit, Ho Chi Minh, Vietnam.
Hoang T HaiOxford University Clinical Research Unit, Ho Chi Minh, Vietnam.
Ho D T NghiaOxford University Clinical Research Unit, Ho Chi Minh, Vietnam.
Nguyen D BangHospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Sofiati DianRadboud University Medical Center, Nijmegen, The Netherlands.
A Rizal GaniemRadboud University Medical Center, Nijmegen, The Netherlands.
Shima ShaporifarDepartment of Medicine, University of Washington, Seattle, Washington, USA.
Vinod KumarRadboud University Medical Center, Nijmegen, The Netherlands.
Zheng LiGenome Institute of Singapore, Singapore, Singapore.
Martin HibberdLondon School of Tropical Medicine and Hygiene, London, United Kingdom.
Chiea Chuen KhorGenome Institute of Singapore, Singapore, Singapore.
Guy E ThwaitesOxford University Clinical Research Unit, Ho Chi Minh, Vietnam.
Dorothee HeemskerkOxford University Clinical Research Unit, Ho Chi Minh, Vietnam.
Arjan van LaarhovenRadboud University Medical Center, Nijmegen, The Netherlands.
Reinout van CrevelRadboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-6233-6410
Sarah J DunstanDepartment of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia.
Javeed A ShahDepartment of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-2997-7988
Radboud University Nijmegen · NLOxford University Clinical Research Unit · VNUniversity of Oxford · GBUniversity of Washington · USGenome Institute of Singapore · SGThe University of Melbourne · AUHospital for Tropical Diseases · VNLondon School of Hygiene & Tropical Medicine · GB

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI CONNIE L CELUM · 1988 to 2026
$104.9M
Systems Biology, Bioinformatics, & Data IntegrationU19AI162583 · NIAID · UNIVERSITY OF WASHINGTON · PI DUNSTAN, SARAH JANE · 2021 to 2025
$13.0M
Systems Genetics of TuberculosisP01AI132130 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BEHAR, SAMUEL M · 2017 to 2021
$11.2M
Systems Genetics of TuberculosisP01AI181898 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CHRISTOPHER M SASSETTI · 2024 to 2026
$10.5M
Seattle Tuberculosis Research Advancement CenterP30AI168034 · NIAID · UNIVERSITY OF WASHINGTON · PI Rhea N Coler, CHETAN SESHADRI · 2022 to 2026
$6.3M
ULTIMATER01AI145781 · NIAID · STICHTING RADBOUD UNIVERSITEIT · PI THWAITES, GUY, VAN CREVEL, REINOUT · 2019 to 2023
$4.4M
TOLLIP Deficiency, Immune Dysregulation, and Tuberculosis SusceptibilityR01AI136921 · NIAID · UNIVERSITY OF WASHINGTON · PI SHAH, JAVEED ALI · 2018 to 2022
$2.5M
Tuberculosis & HIV Co-Infection Training Program in KenyaD43TW011817 · FIC · UNIVERSITY OF WASHINGTON · PI Thomas R Hawn, VIDELIS NDUBA · 2021 to 2026
$1.6M
The impact of vaginal microbiota on cervical dendritic cells: an observational study of women from sub-Saharan Africa at high risk for HIV acquisition.K23HD100221 · NICHD · UNIVERSITY OF WASHINGTON · PI SABO, MICHELLE CATHERINE · 2020 to 2024
$804k
TOLLIP and Tuberculosis ImmunopathogenesisK08AI102971 · NIAID · UNIVERSITY OF WASHINGTON · PI SHAH, JAVEED ALI · 2013 to 2016
$708k
The impact of mucociliary clearance on Mycobacterium tuberculosis pathogenesisR21AI165961 · NIAID · UNIVERSITY OF WASHINGTON · PI SHAH, JAVEED ALI · 2023 to 2024
$457k
FIC NIH HHS D43 TW011817NIAID NIH HHS K08 AI102971NIAID NIH HHS L30 AI091018NIAID NIH HHS P01 AI132130NIAID NIH HHS P01 AI181898NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI168034NIAID NIH HHS R01 AI136921NIAID NIH HHS R01 AI145781NIAID NIH HHS R21 AI165961NIAID NIH HHS U19 AI162583NICHD NIH HHS K23 HD100221Wellcome TrustWellcome Trust 106680/B/14/ZWellcome Trust 206724/Z/17/Z
6 · The paper itself

Abstract

backgroundThe purpose of this study was to assess if single nucleotide polymorphisms (SNPs) in lung mucins MUC5B and MUC5AC are associated with Mycobacterium tuberculosis outcomes.

methodsIndependent SNPs in MUC5B and MUC5AC (genotyped by Illumina HumanOmniExpress array) were assessed for associations with tumor necrosis factor (TNF) concentrations (measured by immunoassay) in cerebral spinal fluid (CSF) from tuberculous meningitis (TBM) patients. SNPs associated with CSF TNF concentrations were carried forward for analyses of pulmonary and meningeal tuberculosis susceptibility and TBM mortality.

resultsMUC5AC SNP rs28737416 T allele was associated with lower CSF concentrations of TNF (P = 1.8 × 10-8) and IFN-γ (P = 2.3 × 10-6). In an additive genetic model, rs28737416 T/T genotype was associated with higher susceptibility to TBM (odds ratio [OR], 1.24; 95% confidence interval [CI], 1.03-1.49; P = .02), but not pulmonary tuberculosis (OR, 1.11, 95% CI, .98-1.25; P = .10). TBM mortality was higher among participants with the rs28737416 T/T and T/C genotypes (35/119, 30.4%) versus the C/C genotype (11/89, 12.4%; log-rank P = .005) in a Vietnam discovery cohort (n = 210), an independent Vietnam validation cohort (n = 87; 9/87, 19.1% vs 1/20, 2.5%; log-rank P = .02), and an Indonesia validation cohort (n = 468, 127/287, 44.3% vs 65/181, 35.9%; log-rank P = .06).

conclusionsMUC5AC variants may contribute to immune changes that influence TBM outcomes.

Indexed as

Mycobacterium tuberculosisTuberculosis, MeningealCytokinesGenotypeHumansMucin 5ACPolymorphism, Single NucleotideTumor Necrosis Factor-alphaCytokinesMUC5AC protein, humanMucin 5ACTumor Necrosis Factor-alphageneticsMUC5ACmucinstuberculous meningitis

Identifiers

PMID36823694
PMCPMC10420404
OpenAlexW4321748713

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.